Alpha Tau Medical (DRTS) Assets Average (2022 - 2026)
Alpha Tau Medical's (DRTS) quarterly Assets Average came in at $107.2 million in Q1 2026, up 28.3% year-on-year from $83.6 million in Q1 2025, and up 1.94% quarter-over-quarter from $105.2 million in Q4 2025.
Alpha Tau Medical (DRTS) Assets Average (2022 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Assets Average across 5 years of filings, most recently posting $107.2 million for Q1 2026.
- Assets Average for Q1 2026 came in at $107.2 million, up 28.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $107.2 million (up 28.3% YoY), and the FY2025 annual result was $95.9 million, down 0.9% from the prior year.
- Assets Average came in at $107.2 million for Q1 2026 at Alpha Tau Medical, up from $105.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $121.7 million in Q3 2022 to a low of $80.6 million in Q1 2022.
- The 5-year median for Assets Average is $106.9 million (2023), against an average of $104.5 million.
- Across the five-year window, Assets Average soared 46.48% in 2023 and fell 20.35% in 2025, its largest moves.
- Alpha Tau Medical's Assets Average stood at $119.8 million in 2022, then retreated by 10.75% to $106.9 million in 2023, then dropped by 17.23% to $88.5 million in 2024, then rose by 18.89% to $105.2 million in 2025, then climbed by 1.94% to $107.2 million in 2026.
- The last three Assets Average figures came in at $107.2 million (Q1 2026), $105.2 million (Q4 2025), and $107.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | 107.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.21 Mn |
| Dec 31, 2025 | 105.17 Mn |
| Sep 30, 2025 | 107.82 Mn |
| Jun 30, 2025 | 95.94 Mn |
| Mar 31, 2025 | 83.57 Mn |
| Dec 31, 2024 | 88.47 Mn |
| Sep 30, 2024 | 93.39 Mn |
| Jun 30, 2024 | 99.25 Mn |
| Mar 31, 2024 | 104.92 Mn |
| Dec 31, 2023 | 106.88 Mn |
| Sep 30, 2023 | 108.79 Mn |
| Jun 30, 2023 | 113.63 Mn |
| Mar 31, 2023 | 118.10 Mn |
| Dec 31, 2022 | 119.76 Mn |
| Sep 30, 2022 | 121.67 Mn |
| Jun 30, 2022 | 121.51 Mn |
| Mar 31, 2022 | 80.63 Mn |